171 related articles for article (PubMed ID: 26055296)
1. Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection.
Li X; Wiesen E; Diorditsa S; Toda K; Duong TH; Nguyen LH; Nguyen VC; Nguyen TH
Vaccine; 2016 Feb; 34(6):869-73. PubMed ID: 26055296
[TBL] [Abstract][Full Text] [Related]
2. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination.
Nguyen TH; Vu MH; Nguyen VC; Nguyen LH; Toda K; Nguyen TN; Dao S; Wannemuehler KA; Hennessey KA
Vaccine; 2014 Jan; 32(2):217-22. PubMed ID: 24284410
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
[TBL] [Abstract][Full Text] [Related]
5. An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
Gidudu JF; Shaum A; Habersaat K; Wilhelm E; Woodring J; Mast E; Zuber P; Amarasinghe A; Nelson N; Kabore H; Abad N; Tohme RA
Vaccine; 2020 Nov; 38(49):7728-7740. PubMed ID: 31337590
[TBL] [Abstract][Full Text] [Related]
6. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
7. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.
Wiesen E; Diorditsa S; Li X
Vaccine; 2016 May; 34(25):2855-62. PubMed ID: 27020710
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal.
Upreti SR; Gurung S; Patel M; Dixit SM; Krause LK; Shakya G; Wannemuehler K; Rajbhandari R; Bohara R; Schluter WW
Vaccine; 2014 Jul; 32(34):4304-9. PubMed ID: 24951865
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Vaccination among 1999⁻2017 Birth Cohorts in Zhejiang Province: The Determinants Associated with Infant Coverage.
Hu Y; Chen Y; Wang Y; Liang H
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30572681
[TBL] [Abstract][Full Text] [Related]
10. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
[TBL] [Abstract][Full Text] [Related]
11. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.
Pham TT; Le HM; Nguyen DT; Maertens K; Leuridan E; Theeten H; Hendrickx G; Van Damme P
Vaccine; 2018 Sep; 36(38):5760-5765. PubMed ID: 30121141
[TBL] [Abstract][Full Text] [Related]
13. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
[TBL] [Abstract][Full Text] [Related]
14. High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
Fougère Y; El Houss S; Suris JC; Rouvenaz-Defago S; Miletto D; Von der Weid L; Willen F; Williams-Smith JA; Gehri M; Crisinel PA
Vaccine; 2018 Jul; 36(30):4501-4506. PubMed ID: 29907480
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
Thornley S; Bullen C; Roberts M
J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
[TBL] [Abstract][Full Text] [Related]
16. Effects of Decreased Immunization Coverage for Hepatitis B Virus Caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020.
Kabore HJ; Li X; Allison RD; Avagyan T; Mihigo R; Takashima Y; Tohme RA
Emerg Infect Dis; 2022 Dec; 28(13):S217-S224. PubMed ID: 36502399
[TBL] [Abstract][Full Text] [Related]
17. Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
Sandhu HS; Roesel S; Sharifuzzaman M; Chunsuttiwat S; Tohme RA
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(30):988-992. PubMed ID: 32730237
[TBL] [Abstract][Full Text] [Related]
18. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
Geier DA; Geier MR
Clin Exp Rheumatol; 2002; 20(6):767-71. PubMed ID: 12508767
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccine adverse events in China: risk control and regulation.
Meina L; Xiaodong L; Lulu Z
Hum Vaccin Immunother; 2014; 10(10):2992-3. PubMed ID: 25483642
[TBL] [Abstract][Full Text] [Related]
20. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992-2006: A mathematical model analysis.
Liang P; Zu J; Yin J; Li H; Gao L; Cui F; Wang F; Liang X; Zhuang G
J Theor Biol; 2015 Dec; 386():115-21. PubMed ID: 26375372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
